Citigroup Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss decreased by 6.8% to $517.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $469.00M to $517.00M. Over 5 years (FY 2020 to FY 2025), Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss shows an upward trend with a 52.2% CAGR.
equity_securities_no_fv_impairment_cumulative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.00M | $76.00M | $87.00M | $80.00M | $86.00M | $103.00M | $219.00M | $254.00M | $282.00M | $299.00M | $338.00M | $351.00M | $356.00M | $385.00M | $438.00M | $469.00M | $501.00M | $511.00M | $555.00M | $517.00M |
| QoQ Change | — | +4.1% | +14.5% | -8.0% | +7.5% | +19.8% | +112.6% | +16.0% | +11.0% | +6.0% | +13.0% | +3.8% | +1.4% | +8.1% | +13.8% | +7.1% | +6.8% | +2.0% | +8.6% | -6.8% |
| YoY Change | — | — | — | — | +17.8% | +35.5% | +151.7% | +217.5% | +227.9% | +190.3% | +54.3% | +38.2% | +26.2% | +28.8% | +29.6% | +33.6% | +40.7% | +32.7% | +26.7% | +10.2% |